FindTrial
Sign In

Survival of Malignant Tumor Patients Based on Fudan University Cancer Registry

Prognostic Study of Hospitalized Cancer Patients Using a Hospital-Based Cancer Registry

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600127358
Enrollment
Unknown
Registered
2026-06-30
Start date
2021-01-01
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Interventions

Malignant tumor:None

Sponsors

Fudan University Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who were hospitalized at Fudan University Shanghai Cancer Center due to malignant tumors and completed tumor treatment (including surgery, radiotherapy, chemotherapy, immunotherapy, etc.) based on preoperative or intraoperative assessment.

Exclusion criteria

Exclusion criteria: 1. Patients who did not receive treatment during hospitalization; 2. Patients with non-malignant tumors.

Design outcomes

Primary

MeasureTime frame
Overall survival, OS;—

Secondary

MeasureTime frame
disease-free survival,DFS;progression-free survival,PFS;—

Countries

China

Contacts

Public ContactZheng Ying

Fudan University Cancer Center

zhengying@fudan.edu.cn+86 186 1633 4507

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026